S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
NASDAQ:THRN

Thorne HealthTech - THRN Stock Forecast, Price & News

$4.46
-0.09 (-1.98%)
(As of 12/9/2022 02:27 PM ET)
Add
Compare
Today's Range
$4.44
$4.57
50-Day Range
$3.50
$5.12
52-Week Range
$3.41
$7.38
Volume
168 shs
Average Volume
130,179 shs
Market Capitalization
$235.67 million
P/E Ratio
74.33
Dividend Yield
N/A
Price Target
$6.83

Thorne HealthTech MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
53.2% Upside
$6.83 Price Target
Short Interest
Healthy
2.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.71mentions of Thorne HealthTech in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
81.08%
From $0.37 to $0.67 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.95 out of 5 stars

Medical Sector

42nd out of 1,022 stocks

Pharmaceutical Preparations Industry

17th out of 499 stocks

THRN stock logo

About Thorne HealthTech (NASDAQ:THRN) Stock

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

THRN Stock News Headlines

Head-To-Head Comparison: Thorne HealthTech (THRN) & Its Rivals
Top Innovation Stock
Today's stock market report features an AI Robotics tech stock with a $4 million order backlog.
Thorne HealthTech (THRN) and The Competition Head to Head Review
Top Innovation Stock
Today's stock market report features an AI Robotics tech stock with a $4 million order backlog.
Thorne HealthTech Reports Third Quarter 2022 Results
Thorne HealthTech Earnings Preview
Thorne HealthTech, Inc. (THRN)
Thorne HealthTech Grows But Faces Macro Headwinds
Thorne HealthTech Rings the Closing Bell
Thorne HealthTech Reports Second Quarter 2022 Results
See More Headlines
Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

THRN Company Calendar

Last Earnings
11/10/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/13/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:THRN
Fax
N/A
Employees
496
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.83
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$5.50
Forecasted Upside/Downside
+53.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$7.25 million
Pretax Margin
2.24%

Debt

Sales & Book Value

Annual Sales
$185.25 million
Cash Flow
$0.28 per share
Book Value
$2.25 per share

Miscellaneous

Free Float
6,394,000
Market Cap
$235.67 million
Optionable
Not Optionable
Beta
0.60

Key Executives

  • Mr. Paul F. Jacobson (Age 67)
    Co-Founder, CEO & Chairman
    Comp: $992k
  • Mr. William C. McCamy (Age 52)
    Pres
    Comp: $550.1k
  • Mr. Thomas P. McKenna (Age 62)
    COO & Director
    Comp: $767.2k
  • Mr. Bryan K. Conley (Age 42)
    Chief Financial Officer
  • Mr. Scott R. Hurth (Age 42)
    Chief Technology Officer
  • Dr. Nathan D. Price Ph.D. (Age 45)
    Chief Scientific Officer & CEO of Onegevity
  • Mr. Thomas Wilson
    VP & Head of Investor Relations
  • Mr. Kim R. Pearson (Age 70)
    Gen. Counsel
  • Ms. Michelle L. Crow (Age 32)
    Chief Marketing Officer
  • Mr. Rob Monteleone
    Sr. VP of Professional Sales













THRN Stock - Frequently Asked Questions

Should I buy or sell Thorne HealthTech stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" THRN shares.
View THRN analyst ratings
or view top-rated stocks.

What is Thorne HealthTech's stock price forecast for 2023?

4 brokerages have issued 1-year price objectives for Thorne HealthTech's shares. Their THRN share price forecasts range from $5.50 to $8.00. On average, they expect the company's stock price to reach $6.83 in the next twelve months. This suggests a possible upside of 50.2% from the stock's current price.
View analysts price targets for THRN
or view top-rated stocks among Wall Street analysts.

How have THRN shares performed in 2022?

Thorne HealthTech's stock was trading at $6.21 on January 1st, 2022. Since then, THRN stock has decreased by 26.7% and is now trading at $4.55.
View the best growth stocks for 2022 here
.

Are investors shorting Thorne HealthTech?

Thorne HealthTech saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 249,700 shares, a decrease of 45.4% from the October 31st total of 457,200 shares. Based on an average daily trading volume, of 66,500 shares, the days-to-cover ratio is currently 3.8 days. Approximately 2.3% of the company's shares are sold short.
View Thorne HealthTech's Short Interest
.

When is Thorne HealthTech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 13th 2023.
View our THRN earnings forecast
.

How were Thorne HealthTech's earnings last quarter?

Thorne HealthTech, Inc. (NASDAQ:THRN) announced its quarterly earnings data on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.03. The firm had revenue of $48.01 million for the quarter. Thorne HealthTech had a net margin of 2.16% and a trailing twelve-month return on equity of 3.72%.

What guidance has Thorne HealthTech issued on next quarter's earnings?

Thorne HealthTech issued an update on its FY 2022 earnings guidance on Friday, December, 9th. The company provided earnings per share guidance of $0.34-$0.37 for the period, compared to the consensus estimate of $0.36. The company issued revenue guidance of $232.00 million-$235.00 million, compared to the consensus revenue estimate of $238.30 million.

When did Thorne HealthTech IPO?

(THRN) raised $98 million in an IPO on Thursday, September 23rd 2021. The company issued 7,000,000 shares at $13.00-$15.00 per share.

What is Thorne HealthTech's stock symbol?

Thorne HealthTech trades on the NASDAQ under the ticker symbol "THRN."

Who are Thorne HealthTech's major shareholders?

Thorne HealthTech's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Emerald Mutual Fund Advisers Trust (1.60%), Vanguard Group Inc. (1.21%), BlackRock Inc. (0.97%), Scout Investments Inc. (0.50%), State Street Corp (0.20%) and Bank of New York Mellon Corp (0.12%).
View institutional ownership trends
.

How do I buy shares of Thorne HealthTech?

Shares of THRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Thorne HealthTech's stock price today?

One share of THRN stock can currently be purchased for approximately $4.55.

How much money does Thorne HealthTech make?

Thorne HealthTech (NASDAQ:THRN) has a market capitalization of $240.42 million and generates $185.25 million in revenue each year. The company earns $7.25 million in net income (profit) each year or $0.06 on an earnings per share basis.

How many employees does Thorne HealthTech have?

The company employs 496 workers across the globe.

How can I contact Thorne HealthTech?

Thorne HealthTech's mailing address is 152 W. 57th Street, New York NY, 10019. The official website for the company is www.thorne.com. The company can be reached via phone at 929-251-6321 or via email at thorneir@edelman.com.

This page (NASDAQ:THRN) was last updated on 12/9/2022 by MarketBeat.com Staff